Skip to content
Free shipping and returns
  • About SUDOSCAN®
  • Our Company
  • Medical Articles
  • Approved Cleaning Products
  • Media & Events
  • Contact Us
  • SUDOSCAN® Shop
  • Log in
  • YouTube
  • LinkedIn
Cart
Subtotal
$0.00
Shipping, taxes, and discount codes calculated at checkout.
Your cart is currently empty.
Refundable Security Deposit for Sudoscan Refundable Security Deposit for Sudoscan Sudoscan Logo white Sudoscan Logo white
  • About SUDOSCAN®
  • Our Company
  • Medical Articles
  • Approved Cleaning Products
  • Media & Events
  • Contact Us
  • SUDOSCAN® Shop
account Log in icon-bag-minimalCart
Access Denied
IMPORTANT! If you’re a store owner, please make sure you have Customer accounts enabled in your Store Admin, as you have customer based locks set up with EasyLockdown app. Enable Customer Accounts
Home / Media & Events / Assessment of Wild-Type Cardiac Amyloidosis and AA Amyloidosis with SUDOSCAN® - JFMA 2020 Study
Neurological diseases · News · Feb 18, 2023

Assessment of Wild-Type Cardiac Amyloidosis and AA Amyloidosis with SUDOSCAN® - JFMA 2020 Study

Image of JFMA 2020 study for the assessment of Wild-Type Cardiac Amyloidosis and AA Amyloidosis with SUDOSCAN®

JFMA 2020: A Multidisciplinary Conference on Amyloidosis in the French Language.

 

In the recent virtual Multidisciplinary French speaking day of Amyloidosis, SUDOSCAN® was presented and showcased its utility in detecting autonomic peripheral neuropathy in AA amyloidosis and wild-type cardiac amyloidosis. Amyloidosis is a rare disease caused by amyloid protein deposits in organs. During the congress, S. Deshayes from Caen Hospital and M. Kharoubi from Henri Mondor University Hospital presented studies on using SUDOSCAN® to detect autonomic neuropathy in AA amyloidosis and wild-type cardiac amyloidosis, respectively. The studies showed promising results in using SUDOSCAN® to monitor and manage these patients. The findings from the studies on wild-type cardiac amyloidosis emphasized the significance of SUDOSCAN® in daily cardiology practice, as it could help identify patients at a higher risk of poor outcomes and optimize their management and monitoring.

Congress session presentation available below:

M. Kharoubi et al (T.Damy). Prevalence and prognostic value of autonomic neuropathy assessed by Sudoscan®

[1] M. Kharoubi et al (T.Damy). Prevalence and prognostic value of autonomic neuropathy assessed by Sudoscan® in transthyretin wild-type cardiac amyloidosis. ESC Heart Failure (2020). Article available here.

Share Share on Facebook Share Tweet on X Pin it Pin on Pinterest

icon-left-arrow Back to Media & Events
Invalid password
Enter
Sudoscan Logo

SUDOSCAN® is a privately-owned French medical device company.

Created in June 2005, SUDOSCAN is located in San Diego, CA, USA; the company's corporate headquarters are in Paris, France. We service all of the North and South America, The Middle East, Europe and Asia.

  • YouTube
  • LinkedIn

Sudoscan

  • About SUDOSCAN®
  • Our Company
  • Medical Articles
  • Approved Cleaning Products
  • Media & Events
  • Contact Us
  • SUDOSCAN® Shop

Shop SUDOSCAN

  • Login
  • Create account
  • SUDOSCAN® Shop

Resources

  • For Physicians
  • Reimbursement Regulatory
  • Approved Cleaning Products
  • For Patients
  • SUDOSCAN® Videos
  • SUDOSCAN® Image Gallery
  • SUDOSCAN® Articles

CONTACT INFO:

US TERRITORIES:
SUDOSCAN Inc.
8525 Gibbs Dr. Suite 304
San Diego, CA 92123

Phone: +1 858 450 2800

INTERNATIONAL:
Impeto Medical
2 Rue Maurice Hartmann,
92130 Issy-les-Moulineaux,
France

Phone: +33 (0)7 87 20 32 03
Website: www.sudoscan.com

Promotional Communication. The medical devices SUDOSCAN® is cleared by the US Food and Drug Administration (FDA). The test allows screening and monitoring of peripheral autonomic neuropathies. It can be performed in diabetic patients or in patients suffering from neurological diseases involving small fibers damage. As with any diagnostic test, its results must be interpreted in a global context including the clinic and other examinations performed. Please read the user manual instructions carefully. Contact our office for more information. Last update: 05/10/2023

  • American Express
  • Diners Club
  • Discover
  • Mastercard
  • Visa
© 2025 SUDOSCAN USA | Autonomic & Sudomotor Testing Device Powered by Shopify
Amyloidosis assessment with SUDOSCAN® - JFMA 2020